Navigation Links
Karnataka Pharmacy Gets Licence to Produce Medicines from White Arecanut

The Arecanut Research and Development Foundation at Mangalore in the southern Indian state of Karnataka has been granted licence for commercial manufacture of two Ayurvedic medicines using white arecanut.//

The areca nut, a favourite of the Indian betel chewers, has been known to have some medicinal properties. It is used in the manufacture of toothpowder and to combat tapeworms.

The Mangalore foundation had initiated research on alternative use of arecanut through the Shri Dharmasthala Manjunatheswara Ayurveda Pharmacy, Udupi.

The the Directorate of Indian Systems of Medicine and Homoeopathy (ISMH) has now given the foundation its nod for commercial production of "Pooga syrup" and "Pooga trim" (powder). Pooga in Sanskrit means arecanut.

M. Mohanan, technical adviser at the pharmacy said in the clinical trails that lasted five years, the syrup was used to treat respiratory-related allergies.

The Pooga trim was used to reduce obesity and control diabetes, he said. The pharmacy was planning to bring out Pooga trim in capsule form too.

He said arecanut constituted 50 per cent of the ingredients in Pooga trim, and 30 per cent in the syrup.

If there was good demand for these medicines, approximately five per cent of the total white arecanut annually produced in Kerala and Karnataka could be utilised to manufacture them, Dr. Mohanan added.There has been a good response from the people of the region during trial marketing and no side-effect reported.
GPL
'"/>




Page: 1

Related medicine news :

1. Bird flu threat ruled out: Karnataka Forest Department
2. Private Public Partnership To Tackle TB, In Karnataka
3. Karnataka Government To Bifurcate Health Services
4. Approval Given for Two Medical Colleges In Karnataka
5. Karnataka CM Gets Praise from Hollywood Superstar
6. Karnataka Chief Minister to Spend Night With HIV Positive Family
7. Karnatakas Free Health Insurance to the Poor
8. Mega Project to Revamp Karnataka’s Healthcar
9. HIV Tests to Be Made Mandatory for Karnataka Couples, Politicians
10. Karnataka Wants to Make HIV Screening Mandatory for Couple Before Marriage
11. Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies
Post Your Comments:
(Date:7/25/2008)...e/ -- Klafter & Olsen LLP has filed a,class action...re" or the,"Company") (Nasdaq: ARTC ) and certain...e Western District of Texas on behalf of all perso...roCare from January 24, 2008,through July 18, 2008...ll,persons or entities who purchased call options ...
(Date:7/25/2008)...iretroviral therapy may be due to genetic factors ...A new study challenges the long-held belief that t...em,s ability to restore itself after HIV patients ...apy (HAART). , From 50 percent to 90 percent of...V. Intravenous drug use is the main cause of both ...
(Date:7/25/2008)...- BeaconEquity.com announces the,availability of T...rs can view all of the daily trading notes for fre...,s Trade Alerts include: DUSA Pharmaceuticals Inc..... (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA), A...daq: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )., J...
(Date:7/25/2008)...gnificant Improvements in Members, Health, ATLANT...er in health,care quality management solutions for...s entered into a long-term agreement with Wellmark...tion on Quality(SM) Incent and,Reward Best Practic...d,primary care clinicians to promote improved qual...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
...Radiologists are enabled to get more detailed imag...advances made in CT scanners, which also serves to... undergo. // Back in 1987, patients had to undergo...table angiograms before going for a bypass surgery...
...Newer antibiotics like cephalosporins will replace...ing ailments like strep throat, as they are seen t...atment given to // 11,426 children, showed that ev...s more effective than the traditional 10-day dose ...
...A new research has revealed that happiness results...hological Bulletin of the American Psychological A...tributes towards // reinforcing positive emotions,...ake new goals and succeed at them. Dr. Sonja Lyu...
...People in general tend to get the blues during the...they recover soon enough. It is far more difficult..., and the people who suffer // from it require hel..., sleep a lot, and tend to put on weight. They exp...
Other Medicine News:Health News:Penicillin To Pave Way For New Antibiotics 2Health News:Happiness Plays An Important Role In Success 2
(Date:7/22/2008)...July 22 /- Following a,thor...rd of Progen,Pharmaceuticals Limited (ASX: PGL; Na...ed the PI-88 phase 3 study in liver cancer. Progen...existing portfolio of compounds and,the company wi...nd,opportunities through Merger & Acquisition acti...
(Date:7/22/2008)...herapeutics Development Initiative bring MJFF,s,cu...eadline January 20,2009, NEW YORK, July 22 /PRNe...eed delivery of transformative treatments and a cu...ndation for Parkinson,s Research has awarded,$2.7 ...teams. The awards,were granted under MJFF,s Therap...
(Date:7/22/2008)...tudy Confirms Tyrima Exhibits Excellent Drug-Like ...Results Support Initiation of Phase II Clinical Tr...Newswire/ -- CeNeRx BioPharma,Inc., a clinical st...ive,treatments for diseases of the central nervous... candidate Tyrima(TM) into Phase II trials for the...
(Date:7/22/2008)...Calif., July 22 /- Hyperion,Therapeut...tient enrollment,in its Phase 1/2 clinical trial t...avenging effects of HPN-100 (formally called GT4P)...ients with urea cycle disorders,(UCD). The company...quarter,of this year., (Logo: http://www.newscom...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Many African Americans have a gene that prolongs life after heart failure 2966 1Many African Americans have a gene that prolongs life after heart failure 2966 2Many African Americans have a gene that prolongs life after heart failure 2966 3Many African Americans have a gene that prolongs life after heart failure 2966 4Allergies Can Dig Into Gardenings Fun 17255 1Allergies Can Dig Into Gardenings Fun 17255 2BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 4712 1BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 4712 2BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 4712 3Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 1Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 2Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 3Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 4
...BRIDGE, Mass.--(BUSINESS WIRE)--Apr 12, 2007 - AVE...ny focused on the,discovery and development of nov...t it will present a total of 12 oral and poster,pr... Research,(AACR) Annual Meeting on April 14-18, 20...ted to share with the cancer community the,pioneer...
...NDON, April 12, 2007--The costs of eradicating,pol...while high in,the short term, are much lower than ...s without eradication. And a recently developed,mo...ive against,type 1 poliomyelitis than an existing ...rticles published Online and in an upcoming,issue ...
Other Medicine Technology:AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR 2AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR 3Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
Angled for temporal approach. Solid 14 mm blades. Dull finish.
Solid 8 mm blades. Dull finish. Most popular size or model.
Closed wire 5 mm blade with a wing tip twist giving the surgeon better on-axis accessibility.
Angled for temporal approach. Wire 14 mm rounded blades for patient comfort. Dull finish.
Medicine Products: